a r t i c l e s Lentiviral genomes encode Gag, Pol and Env proteins along with six accessory proteins 1 , which facilitate virus replication in vivo 2, 3 . The accessory viral protein R (Vpr), a 14-kDa protein, is highly conserved in HIV and simian immunodeficiency virus (SIV) 4 and is involved in many processes that affect the pathophysiology of AIDS 5 .
Vpr is incorporated into budding virions via interaction with the C terminus of Gag, and during virus maturation it is recruited by viral RNA into the conical capsid core of the virus particle 6 . Because the core is released into the cytoplasm of a newly infected cell, Vpr is poised to play important roles in immediate post-entry events.
The most dramatic and widely acknowledged phenotype of Vpr expression in cycling cells is the induction of cell-cycle arrest in G2-M phase 7, 8 . The determinants of Vpr's activity in cell-cycle arrest are not fully understood, but there is compelling evidence that Vpr executes its function by engaging DDB1-and CUL4A-associated factor 1 (DCAF1), the substrate-recognition subunit of CRL4, which comprises cullin4A (CUL4A), RING H2 finger protein 1 (RBX1) and DNA damage-binding protein 1 (DDB1), and recruits cellular targets to the ligase for proteasome-mediated degradation [9] [10] [11] [12] [13] [14] [15] . Vpr mutants that abolish the interaction with DCAF1 eliminate cell-cycle arrest, as does silencing of DCAF1 (refs. 9-12,15) .
Subversion of the host ubiquitin-proteasome pathway is commonly exploited by lentiviral accessory proteins. Viral infectivity factor (Vif) and Viral protein U (Vpu) target apolipoprotein B mRNA-editing, enzymecatalytic, polypeptide-like 3G (APOBEC3G) and bone marrow stromal cell antigen 2 (BST2) or tetherin, respectively, by co-opting specific CRL E3 ubiquitin ligases and altering their substrate specificities [16] [17] [18] .
HIV-1 Vpr directs the CRL4-DCAF1 E3 ubiquitin ligase complex toward several cellular substrates. For example, levels of MUS81, a component of the Holliday junction resolvase SLX4 complex, are downregulated in a Vpr-and DCAF1-dependent manner 19 , and degradation of minichromosome maintenance complex component 10 (MCM10), a known target of CRL4-DCAF1, is enhanced by Vpr 20 .
Viral protein X (Vpx) of HIV-2 and SIV, which have evolved from a common ancestor of Vpr, binds to the same CRL4-DCAF1 E3 ubiquitin ligase and targets the sterile alpha motif and histidine/aspartatecontaining protein 1 (SAMHD1) for degradation [21] [22] [23] . SAMHD1 is an HIV restriction factor that acts by depleting the intracellular pool of deoxynucleoside triphosphates to levels below those required for the synthesis of the viral DNA by reverse transcriptase 24 . The structural basis of clade-specific SAMHD1 recruitment to the DCAF-Vpx complex has recently been elucidated [25] [26] [27] . However, no structural data on the interaction between DDB1 and DCAF1 or DCAF1 and Vpr are available, and very little is known about how the closely related Vpr and Vpx proteins impart different substrate specificity to the same CRL4-DCAF1 E3 ligase for the selective recruitment of cellular targets.
The first identified target of HIV-1 Vpr-mediated redirection of the CRL4-DCAF1 E3 ubiquitin ligase was the nuclear isoform of UNG2 (refs. 28,29) . This enzyme recognizes and removes uracil bases from DNA, thereby catalyzing the first step in the base excision repair pathway 30 . The resulting abasic sites are fully repaired during subsequent steps. HIV-1 DNA acquires uracil through a variety of mechanisms, including APOBEC3-mediated deamination of cytidine residues in a r t i c l e s viral reverse transcripts and uracil misincorporation by viral reverse transcriptase [31] [32] [33] . Therefore, HIV-1 cDNA is a potential substrate for UNG2-mediated processing.
UNG2 is antagonized by HIV-1 Vpr. HIV-1 Vpr loads UNG2 onto CRL4-DCAF1 E3 for polyubiquitination and subsequent proteasomemediated degradation 29 . As a result, UNG2 levels are depleted, and uracil base excision repair is compromised in HIV-1-infected primary target cells 34, 35 . Whereas the above findings provide strong evidence for a role of UNG2 in HIV-1 infection, deciphering the details of UNG2's effects have remained elusive to date. Evidence in support of a positive role 36, 37 , a negative role 38 or no role 39 in HIV-1 replication have been reported, thus suggesting a more nuanced, possibly cell-type-specific role of UNG2 in HIV-1 infection.
To better understand the molecular mechanism underlying HIV-1 Vpr-mediated UNG2 downregulation through the CRL4 E3 ubiquitin ligase machinery, we determined the crystal structure of HIV-1 Vpr in complex with human UNG2 and the CRL4 acceptor-receptor proteins DDB1-DCAF1. We found that Vpr binds DCAF1 in a similar manner to Vpx, primarily through the N-terminal tail and α-helix α3, despite limited sequence similarity in these regions of Vpr and Vpx. Interestingly, for the UNG2 interaction, Vpr uses structural mimicry of DNA and engages the DNA-binding region of UNG2 in a cleft between helices α1 and α2. Together, our findings reveal a dual mechanism used by HIV-1 Vpr to antagonize UNG2: one involves degradation by the proteasome, and the other entails inhibition through molecular mimicry. The latter mechanism is also used by the bacteriophage gene product Ugi to inhibit a prokaryotic uracil-DNA glycosylase 40 .
RESULTS

Structure of the DDB1-DCAF1-Vpr-UNG2 complex
We used crystals of the DDB1-DCAF1-Vpr-UNG2 complex for structure determination ( Table 1 and Online Methods) and solved the structure by molecular replacement, using the structure of each protein component as search models: DDB1 (PDB 3E0C) 41 , DCAF1 (PDB 4Z8L) 27 , Vpr (PDB 4Z8L) 27 and UNG2 (PDB 2OYT) 42 . We subjected the initial model to several rounds of manual model building. The use of B-factor sharpening permitted visualization of most amino acid side chains ( Fig. 1a; final 2F o − F c map of the complex in Fig. 1b and Supplementary Fig. 1a-d) .
The structure includes approximately 1,800 residues per monomer in the asymmetric unit (ASU), including full-length human DDB1; the C-terminal region of DCAF1, including the WD40 domain (residues 1046-1396); full-length HIV-1 Vpr; and the catalytic domain of human UNG2 (residues 83-304) ( Fig. 1c and Supplementary  Fig. 1f ). Two copies of the heterotetramer complex were present per ASU, and they pack against each other (Supplementary Fig. 1e) , with UNG2 forming extensive contacts with DDB1, DCAF1 and Vpr from the symmetry-related molecule, thus suggesting that the presence of UNG2 was critical for crystallization ( Supplementary Fig. 1g ). These contacts, however, are solely crystallographic, because sizeexclusion chromatography and multiangle light-scattering experiments revealed that only a monomeric complex was present in solution ( Supplementary Fig. 1h) . The four components in the complex are arranged in series, with DDB1 binding to DCAF1, which interacts with Vpr, which in turn binds to UNG2 (Fig. 1c) , thus resulting in an overall length of the complex of 170 Å.
Vpr mimics UNG2 binding to DNA Vpr forms a three-helix bundle in the complex, and the helical arrangement is very similar to that in the solution NMR structure solved at low pH 43 . Four structural motifs important for Vpr's interaction with partners are discernible: a random-coil N-terminal tail; a hydrophobic cleft formed by helices α1, α2 and the first turn of α3; the loop connecting α2 and α3 (insert loop); and the C-terminal region of helix α3 (Supplementary Fig. 2a ). Vpr interacts with DCAF1 by using its N terminus and helix α3 (described below) and interacts with UNG2 via the insert loop and residues in the hydrophobic cleft, burying a surface area of 1,650 Å 2 and 940 Å 2 , respectively (Supplementary Fig. 2b) .
Intriguingly, the binding site of UNG2 that is contacted by Vpr is essentially identical to that in the UNG2-DNA complex (Fig. 2a,b and Supplementary Fig. 2c ). In particular, the loop (residues 266-283) of UNG2 that interacts with DNA uses Leu272 to insert into the minor groove 42 ; in the DDB1-DCAF1-Vpr-UNG2 complex, Leu272 inserts deeply into the cleft of Vpr (Fig. 2c) . We tested the importance of Leu272 of UNG2 for Vpr binding by mutagenesis (Fig. 2d) . In coimmunoprecipitation experiments, the interaction between Vpr and UNG2 was substantially affected by the L272D mutation (Fig. 2d) . In addition, the L272D mutant was resistant to Vpr-mediated downregulation, whereas a substantial reduction in UNG2 levels was observed after transient cotransfection of Vpr and WT UNG2 (Fig. 2d) .
The insert loop of Vpr engages UNG2 via a proline-rich motif (165-PPPPS-169), thereby creating a second interface. Stacking interactions between Asp52 and Trp54 of Vpr and Pro168 of UNG2 are present (Fig. 2c,e) , as well as hydrogen-bonding between Tyr47 of Vpr and His268 of UNG2, and Asp52 of Vpr and Tyr147 of UNG2 (Fig. 2e,f) . In agreement with this observation, the Vpr mutants W54R and W54G do not bind UNG2 (ref. 44 ) and lose the ability to downregulate UNG2 in cells 22, 35, 36 . Interestingly, the Vpr insert loop mimics the phosphate 59 . c Data set used only to obtain the initial molecular replacement model. npg a r t i c l e s backbone trace around the abasic sugar in the DNA ( Supplementary  Fig. 2d-f) . A similar mechanism of molecular mimicry has been observed in the crystal structure of human UNG2 bound to Bacillus subtilis bacteriophage uracil-DNA glycosylase inhibitor (Ugi), a 9.5-kDa protein 40 . However, the two structures are very different in architecture: Ugi contains a five-strand antiparallel β-sheet flanked by two α-helices, whereas Vpr consists of a three-α-helix bundle. Glu20 of Ugi and Asp52 of Vpr interact with UNG2's DNA-binding site ( Supplementary Fig. 2g ), and UNG2's Leu272 ( Supplementary  Fig. 2h ) inserts into their respective pockets.
To test whether binding of Vpr to UNG2 might effectively inhibit the enzyme's activity, we performed base excision and inhibition assays with a single-stranded uracilated DNA substrate 36 . In the presence of the DDB1-DCAF1-Vpr complex, but not DDB1-DCAF1 alone, substrate cleavage was inhibited (Supplementary Fig. 2i ), thus confirming our hypothesis that Vpr mimics DNA and thereby interferes with substrate binding.
Vpr binding to the DCAF1 WD40 domain
The DCAF1 construct in the present complex includes a helix-loophelix motif (Phe1050-Arg1079) at the N terminus and the canonical seven-blade WD40 β-propeller domain (Arg1081-Glu1388; Supplementary Fig. 3a) . The surface of the β-propeller is not flat; loops connecting the β-strands on one hemisolenoid of the propeller create a large cleft, where Vpr binds ( Fig. 3a and Supplementary  Fig. 3b-d) . The cleft is lined with acidic residues at one end (Supplementary Fig. 3b ) and hydrophobic residues at the center (Fig. 3a) . Residues Arg62, Gln65 and Arg73 on α3 of Vpr form hydrogen bonds with Glu1088, Ser1136 and Thr1139 of DCAF1, respectively (Fig. 3b) . In addition, Vpr Phe69 is buried inside a small hydrophobic pocket formed by residues Ala1137, Phe1330 and Phe1355 of DCAF1 ( Fig. 3b and Supplementary Fig. 3d ). On Vpr, Glu25, Leu26 and Glu29 on α1 and Gln65 and Leu68 on α3 form a small pocket into which DCAF1 residue Trp1156 binds ( Fig. 3b  and Supplementary Fig. 3d) . Furthermore, the N-terminal tail of Vpr wraps around one side of the propeller, following a small groove between two blades (Fig. 3c) .
We validated several contacts by immunoprecipitation (Fig. 3d,e) . DCAF1 binding was substantially reduced in the Vpr R62D mutant (Fig. 3d) , whereas we observed no stable binding to Vpr with DCAF mutant W1156A, thus demonstrating the critical interaction between residues in α1 of Vpr and Trp1156 of DCAF1 (Fig. 3d) . The disruption of hydrophobic interactions between Phe69 of Vpr and Phe1330 and Phe1335 of DCAF1 by alanine substitution of any of these residues abolished complex formation (Fig. 3e) .
DCAF1 is anchored into DDB1 by a helix-loop-helix motif
The N-terminal helix-loop-helix of DCAF1 anchors DCAF1 into DDB1 (Supplementary Fig. 3a ). DDB1 is a large multidomain protein comprising three WD40 β-propeller domains (BPA, BPB and BPC) and a C-terminal helical domain 45, 46 . BPA and BPC pack against each other at approximately a 65° angle, forming a large opening (approximately 28 Å in diameter) at the interface of the two propellers ( Supplementary  Fig. 3e-g ). Helix α1 and the loop bind inside this opening, and helix α2 lines the entrance of the opening. The orientation of the helices in the helix-loop-helix region is stabilized by hydrogen bonds between the Arg1053 side chain and the backbone carboxyl group of Ala1046 and the side chain of Asp1072 (Supplementary Fig. 3h ). Intermolecular contacts Fig. 3h ). Additional DDB1-DCAF1 interactions include contacts between DCAF1 loops with BPA and BPC residues on the opposite site of the Vpr-binding site. We used mutagenesis to probe the importance of specific residues in this interaction: replacement of amino acids in the helix-loop-helix motif of DCAF1, such as R1053E and R1057E, abolished binding to DDB1 (Supplementary Fig. 3i ).
Helix-loop-helix motifs are commonly found in substrate receptor proteins that bind to DDB1 of the CRL4 E3 ubiquitin ligase [46] [47] [48] [49] . Comparison of the current DDB1-DCAF1 arrangement with the arrangement in the complex of DDB1 with the DNA-repair protein DNA-damage-binding protein 2 (DDB2) revealed that components of both complexes interact in very similar fashion 47, 48, 50 . Structural alignment between DCAF1 and DDB2 (PDB 4A0L) 47 yielded an r.m.s. deviation of 3.02 Å for Cα atoms and a Z score of 7.5, despite only 8% amino acid sequence identify. Consequently, different amino acids are involved in the interaction. Most interestingly, however, structural superposition of Vpr-bound DCAF1 and DNA-bound DDB2 indicates that Vpr and damaged DNA interact with very similar regions on the surface of DCAF1 and DDB2, respectively, thus suggesting that Vpr engages in structural mimicry (Supplementary Fig. 3j,k) .
Vpr recruits substrates differently from Vpx
Comparisons of the Vpr structure with Vpx from SIV revealed canonical, yet distinctive, modes of binding to DCAF1 and their specific cellular substrates. Two structures of Vpx complexes have been determined, one containing Vpx from mandrill SIV (Vpx MND , PDB 5AJA and PDB 4Z8L) 26, 27 and the other with Vpx from sooty mangabey SIV (Vpx SM , PDB 4CC9) 25 . In both structures, Vpx forms a very similar three-helix bundle, with an r.m.s. deviation (among Cα atoms) of 1.21 Å. The Vpr architecture in the current structure is similar to both Vpx MND and Vpx SM , with r.m.s. deviations of 1.57 Å and 1.58 Å, respectively, for the helical part (Vpr residues 15-74). Despite this similarity in overall structure, functionally important differences influencing specific substrate recruitment can be discerned: in particular, the cleft in the Vpr structure, which is used by UNG2 (Fig. 4a and Supplementary  Fig. 4a ), is absent in Vpx because of the presence of bulky side chains, such as Trp45 and Tyr67 in Vpx MND , and Trp49 and Tyr71 in Vpx SM (Supplementary Fig. 4b,c) . In addition, Vpx contains a much longer insert loop than Vpr, and the amino acid sequence identity in the loop is not conserved between Vpr and Vpx. This region of the Vpr structure is intimately involved in the UNG2 interaction, and it is unlikely that a long insert loop could be accommodated (Fig. 4b) . Thus, the length and residue type of the insert loop of Vpr and Vpx are important determinants of binding specificity.
Despite low amino acid sequence identity between Vpr and Vpx ( Supplementary Fig. 4g ), in the interaction with DCAF1, the same structural elements are used, namely the N-terminal tail and helix α3. However, at each contact point, different amino acids are engaged, although the lengths and shapes of the residues tend to be similar (Fig. 4c) . Moreover, in Vpr, in contrast to Vpx, no residues establish hydrogen-bonding interactions with the acidic loop of DCAF1 (Supplementary Fig. 4d and refs. 25,26) . However, for the N-terminal npg a r t i c l e s tail of Vpr and Vpx, the structure indicates a different path along the DCAF1 binding surface (Fig. 4d) . This path is partly caused by the presence of the N-terminal tail of SAMHD1 in the Vpx complex, which intertwines between DCAF1 and Vpx ( Fig. 4e and Supplementary  Fig. 4e) , thus illustrating the remarkable plasticity used by Vpr and Vpx proteins in engaging their interaction partners. Binding of Vpr to UNG2 involves the cleft between helices α1 and α2 on Vpr, whereas binding of Vpx to SAMHD1 involves helix α2 (Fig. 4e,f) , the N-terminal tail and the insert loop ( Supplementary  Fig. 4d-f) . Thus, it appears that the Vpr and Vpx families of proteins use related, but distinct, structural regions to bind and recruit cellular targets to the E3 ligase complex, thus ultimately targeting the substrates for degradation by the proteasome.
DISCUSSION
By promoting physical interactions with cellular proteins and modulating the output of cellular signaling events, retroviral accessory proteins manipulate these signaling pathways and thereby enhance viral replication. This phenomenon is clearly seen for HIV-1 Vpr, which acts as a molecular bridge using nonoverlapping surfaces to link DCAF1 and UNG2. The binding interface with DCAF1 predominantly involves hydrophobic residues on helix α3 and Vpr's N-terminal disordered tail. The interface with UNG2 comprises Vpr's insert loop and cleft, and the DCAF1-Vpr interaction enhances DCAF1 binding to DDB1 (ref. 51) .
Although both Vpr and Vpx are packaged into virions and are delivered into host cells after viral infection, their presence results in completely different phenotypic outcomes: Vpx strongly enhances lentiviral infection in monocytes and monocyte-derived dendritic cells, whereas HIV-1 Vpr promotes virus replication in macrophages 52 , possibly by overcoming macrophage-specific restriction of Env expression 53 , and triggers cell-cycle arrest at G2 in cycling cells 7, 8, 54, 55 . These different outcomes caused by Vpr and Vpx are mediated via recruitment of the same CRL4-DCAF1 E3 ubiquitin ligase, but by targeting and loading different cellular substrates [9] [10] [11] [12] [13] [14] [15] 54, 55 . Our structure explains how these different outcomes are achieved through use of different regions for substrate binding (Fig. 4f,g ). Vpr uses the binding cleft between the α1 and α2 helices to engage UNG2 (Fig. 4a) , whereas Vpx uses its N-terminal tail and helix α2 to bind SAMHD1 (Fig. 4g) .
The crystal structures of Vpr and Ugi bound to UNG2 illustrate how these two proteins engage in molecular mimicry of DNA binding. Both block the active site of UNG2, and this steric obstruction impairs the enzymatic activity of UNG2 (Supplementary Fig. 2i ) and thus the first step in repair of uracilated DNA. Although Vpr and Ugi exhibit strikingly different protein folds, both bind the UNG2 residue Leu272, which is used in DNA binding, and similar surface areas are [45] [46] [47] [48] 50) . In the present structure, DCAF1 also interacts with DDB1 through the helix-loop-helix motif (Supplementary Fig. 3a) , although the lengths of the helices and their orientation differ from those in the DDB1-DBB2 structure (Supplementary Fig. 3f ). It appears that the helix-loop-helix motif is not the only region interfacing with DDB1, and the WD40 propeller domain may potentially play an additional role. This possibility is likely to apply to the majority of DCAFs, because 52 of 60 DCAFs possess a WD40 propeller in addition to the helixloop-helix motif 56 . Indeed, within the WD40 propeller of DCAF1, a conserved WDXR motif has been found to be important in the interaction with DDB1 (ref. 57 ). In the current structure, Arg1283 of DCAF1 interacts with Glu201 in the BPA domain of DDB1.
Thus, DCAF1 interacts with DDB1 similarly to other substrate receptors of the CRL4 E3 ubiquitin ligase, by using the common helix-loophelix and WDXR motifs.
The hinge connecting the BPB β-propeller to the clam-shaped BPA-BPC double propeller (Supplementary Fig. 3e ) allows for large conformational changes and enables positioning of the substrates for accepting the ubiquitin mark 47 . To evaluate how HIV-1 Vpr may function in host-factor recruitment to the CRL4-DCAF1 E3 ubiquitin ligase machinery, and in particular how human UNG2 is positioned for ubiquitination, we built a molecular model of the entire CRL4-DCAF1-Vpr-UNG2 assembly by superimposing the BPA-BPC portion of DDB1 of the current structure onto the BPA-BPC portion of DDB1 in the DDB1-CUL4A-RBX1 structure (Fig. 5a, PDB 2HYE ) 57 . Our model shows a 30° rotation of the BPB β-propeller with respect to the BPB propeller in PDB 2HYE 57 (Supplementary Fig. 5 ). In this orientation, Vpr bridges DCAF1 to UNG2, such that UNG2 is placed within 10 Å of RBX1 (Fig. 5b,c) . Positioning of UNG2 next to RBX1 in the overall complex should allow for polyubiquitination of UNG2, which is necessary for proteasomal degradation.
Retroviral accessory proteins frequently antagonize antiviral proteins, thereby promoting virus replication in host cells [16] [17] [18] . They frequently achieve their function by co-opting host cellular E3 ubiquitin ligases and loading restriction factors onto the ligases for npg a r t i c l e s ubiquitination and proteasome-dependent degradation. Our present findings demonstrate that Vpr uses a powerful dual mechanism to antagonize UNG2. One step exploits molecular mimicry to block substrate recognition by UNG2. The other involves proteasomedependent degradation of UNG2, with the UNG2-Vpr complex being loaded onto CRL4-DCAF1 E3. Importantly, inspection of HIV-1 Vpr protein sequences deposited in the LosAlamos database (http://www. hiv.lanl.gov/content/index/) revealed that the Vp r interaction surface for UNG2 is well conserved among HIV-1 and SIVcpz Vpr proteins, as is Vpr's ability to antagonize UNG2 (ref. 34 ). This strong conservation of Vpr's UNG2 antagonism in HIV-1 and SIVcpz lineage viruses is consistent with the possibility that UNG2 exerts a negative effect on HIV-1 replication. Further virologic studies are required to resolve these issues. Our structural data support a general mechanism of Vpr-mediated host-factor ubiquitination, which is accomplished by the viral protein modifying the substrate-binding surface of the host adaptor protein DCAF1. In addition, our biochemical data show that Vpr binding to UNG2 results in inhibition of UNG2's enzymatic activity, which in turn might also contribute to Vpr-mediated infectivity. Thus, Vpr delivers a two-step 'punch' , inhibiting UNG2 enzymatic activity and steering it toward destruction via the host degradation machinery. Having established the structural and molecular basis of the assembly of the viral modified E3 ubiquitin ligase machinery, our studies should provide a foundation for improved understanding of Vpr's functions in viral replication and in pathogenesis. 
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